Home  >  News
Eppen_Ultracentrifuge_May2026
you can get e-magazine links on WhatsApp. Click here
News
  EktaH’s lead compound NKS-3 shows 50% reduction in post-GLP-1 weight rebound with novel obesity treatment & reports positive phase I data,   May 14, 2026
  AstraZeneca announces eneboparatide normalised serum calcium and achieved independence from active vitamin D and oral calcium supplements in 31.1% of adults with hypoparathyroidism at week 24 in CALYPSO phase III trial,   May 14, 2026
  Novo Nordisk’s higher dose Wegovy shows 28% weight loss in early responders according to new analyses,   May 13, 2026
  AskBio doses first patient in phase 1/phase 2 gene therapy trial of AB-1009 for late-onset pompe disease,   May 13, 2026
  Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at ASCO 2026,   May 13, 2026
  Anixa Biosciences announces updated positive survival observations from ongoing phase 1 trial of lira-cel ovarian cancer CAR-T therapy,   May 12, 2026
  Ten-year pivotal data reinforce the long-term durability of Edwards’ RESILIA tissue,   May 12, 2026
  Mabwell’s IND application for 9MW5211 to treat inflammatory bowel disease receives US FDA clearance to begin clinical studies,   May 11, 2026
  Oculis announces agreement with US FDA on a Special Protocol Assessment for optic neuritis registrational trial,   May 09, 2026
  Bayer announces positive results from phase III REVEAL study of investigational PET/CT radiotracer 124 evuzamitide,   May 08, 2026
  Samsung Bioepis announces positive preliminary phase 1 study data for SB27, proposed biosimilar to Keytruda,   May 08, 2026
  GSK to present 33 abstracts on latest respiratory research to advance patient care at ATS 2026,   May 08, 2026
  Cellenkos receives US FDA clearance to initiate phase 1b/2a trial of CK0802 in steroid-refractory graft-versus-host disease,   May 07, 2026
  Johnson & Johnson announces positive results from phase 3 FUZION study of Tremfya in perianal fistulizing Crohn's disease,   May 07, 2026
  Alebund Pharma completes patient enrollment in global phase III pivotal multi-regional clinical trial of AP301 for hyperphosphatemia,   May 07, 2026
  J&J investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease,   May 07, 2026
  Prolacta Bioscience’s JASMINE trial shows human milk-based fortifiers deliver superior growth in premature infants while maintaining Japan’s renowned low NEC rate,   May 06, 2026
  Altesa BioSciences begins enrolment in phase 2b CARDINAL trial of vapendavir as transformational treatment for patients with COPD impacted by rhinovirus,   May 06, 2026
  Anteris Technologies announces first US patients treated in global pivotal PARADIGM trial,   May 06, 2026
  Lilly's Omvoh is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years,   May 06, 2026

  • Results Found: 16984
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 850
 Back
 
Propak_Asia_2026
APME-2026.gif
echemi_logo26
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram